Health Reform Taxes: Senate Reduces Device Fee, Adds Cosmetic Surgery Tax
This article was originally published in The Pink Sheet Daily
The consolidated Senate bill, which will be taken up for debate on the floor next week, includes a $2 billion-per-year, 10-year annual fee on device manufacturers and importers.
You may also be interested in...
St. Jude Medical CEO Daniel Starks has resigned from AdvaMed's board of directors and the company has left the organization, citing "strong dissent" over how to respond to proposed medical device fees in pending health reform legislation
The updated House health care reform bill includes a substantially reduced device industry excise tax compared to a Senate bill, but includes no exceptions for small businesses
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.